OAKLAND, Calif., Oct. 02, 2023 (GLOBE NEWSWIRE) — Promaxo, Inc. (“Promaxo” or the “Company”), a medical imaging, robotics, and AI technology company, today announced the sale of 20 systems in the third quarter ending September 30, 2023. System sales were made through the Company’s various sales programs to physician practices, ambulatory surgery centers (ASC), and integrated delivery network (IDN) facilities.
Notable Promaxo system sales in the third quarter include those made to:
- Summit Health, a provider of primary, specialty and urgent care in the United States with more than 370 locations, who purchased two systems;
- University Urology Associates of New Jersey, a urology practice with five locations across New Jersey, who purchased two systems;
- Academic Urology & Urogynecology of Arizona, a provider of urology and urogynecology services across Arizona with nine locations, who purchased two systems for their ASC and office locations; and
- Rhode Island Hospital, the principal teaching hospital of The Warren Alpert Medical School of Brown University, who purchased their first system.
Promaxo has sold a total of 52 systems through the first nine months of 2023, compared to 13 systems during the same prior year period. The Company has sold a total of 77 systems across 26 states since its commercial launch in the fourth quarter of 2021.